These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2890188)

  • 21. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability.
    Christian L; Snycerski SM; Singh NN; Poling A
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():88-93. PubMed ID: 10221788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmentally disabled, doubly disadvantaged.
    Parker G
    Med J Aust; 1991 Jul; 155(2):68-71. PubMed ID: 1857308
    [No Abstract]   [Full Text] [Related]  

  • 23. Support staff's perceptions of discontinuing antipsychotics in people with intellectual disabilities in residential care: A mixed-method study.
    Kleijwegt B; Pruijssers A; de Jong-Bakker L; de Haan K; van Os-Medendorp H; van Meijel B
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):861-870. PubMed ID: 30790388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
    Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
    Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with psychotropic medication in mental retardation facilities.
    Tu J; Smith JT
    Compr Psychiatry; 1979; 20(3):289-95. PubMed ID: 446009
    [No Abstract]   [Full Text] [Related]  

  • 26. Polypharmacy in the treatment of subjects with intellectual disability.
    Häβler F; Thome J; Reis O
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S93-100. PubMed ID: 24858727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prescribing of neuroleptic drugs for people with learning disabilities living in Leicestershire.
    Branford D; Collacott RA; Thorp C
    J Intellect Disabil Res; 1995 Dec; 39 ( Pt 6)():495-500. PubMed ID: 8746736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations in the use of psychotropic drugs in elderly mentally retarded persons.
    Aman MG
    J Ment Defic Res; 1990 Feb; 34 ( Pt 1)():1-10. PubMed ID: 2182880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
    Harper DC; Wadsworth JS; Michael AL
    Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychotropic drug prescription to people with intellectual disability in GP practices].
    Bakker-van Gijssel EJ; Leusink GL
    Ned Tijdschr Geneeskd; 2015; 159():A9754. PubMed ID: 26629605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tranquilizer reduction trials in a residential program for persons with mental retardation.
    Spreat S; Serafin C; Behar D; Leiman S
    Hosp Community Psychiatry; 1993 Nov; 44(11):1100-2. PubMed ID: 7904579
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded.
    Aman MG; Singh NN; Fitzpatrick J
    J Autism Dev Disord; 1987 Dec; 17(4):511-23. PubMed ID: 3680153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.
    Linaker OM
    Br J Psychiatry; 1990 Apr; 156():525-30. PubMed ID: 1974820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students.
    Cullinan D; Gadow KD; Epstein MH
    J Abnorm Child Psychol; 1987 Dec; 15(4):469-77. PubMed ID: 3437084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of the residential environment in board-and-care homes for mentally and developmentally disabled persons.
    Wilson J; Kouzi A
    Hosp Community Psychiatry; 1990 Mar; 41(3):314-8. PubMed ID: 2312079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
    Hogg J
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.